Annual Operating Expenses
$172.55 M
-$54.90 M-24.14%
31 December 2023
Summary:
Heron Therapeutics annual total operating expenses is currently $172.55 million, with the most recent change of -$54.90 million (-24.14%) on 31 December 2023. During the last 3 years, it has fallen by -$108.06 million (-38.51%). HRTX annual operating expenses is now -41.52% below its all-time high of $295.04 million, reached on 31 December 2019.HRTX Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$27.81 M
-$4.14 M-12.96%
30 September 2024
Summary:
Heron Therapeutics quarterly total operating expenses is currently $27.81 million, with the most recent change of -$4.14 million (-12.96%) on 30 September 2024. Over the past year, it has dropped by -$10.35 million (-27.11%). HRTX quarterly operating expenses is now -65.81% below its all-time high of $81.34 million, reached on 31 March 2019.HRTX Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HRTX Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -24.1% | -27.1% |
| 3 y3 years | -38.5% | -56.3% |
| 5 y5 years | -26.2% | -53.9% |
HRTX Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -38.5% | at low | -62.9% | at low |
| 5 y | 5 years | -41.5% | at low | -64.6% | at low |
| alltime | all time | -41.5% | +3351.1% | -65.8% | +2628.2% |
Heron Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $27.81 M(-13.0%) |
| June 2024 | - | $31.95 M(+3.0%) |
| Mar 2024 | - | $31.02 M(-10.3%) |
| Dec 2023 | $172.55 M(-24.1%) | $34.57 M(-9.4%) |
| Sept 2023 | - | $38.16 M(-29.4%) |
| June 2023 | - | $54.01 M(+17.9%) |
| Mar 2023 | - | $45.82 M(+21.4%) |
| Dec 2022 | $227.46 M(-11.9%) | $37.76 M(-29.7%) |
| Sept 2022 | - | $53.72 M(-11.9%) |
| June 2022 | - | $60.95 M(-18.8%) |
| Mar 2022 | - | $75.03 M(+18.6%) |
| Dec 2021 | $258.15 M(-8.0%) | $63.25 M(-0.5%) |
| Sept 2021 | - | $63.59 M(-7.0%) |
| June 2021 | - | $68.39 M(+8.7%) |
| Mar 2021 | - | $62.92 M(-13.2%) |
| Dec 2020 | $280.61 M(-4.9%) | $72.51 M(+1.9%) |
| Sept 2020 | - | $71.18 M(+2.5%) |
| June 2020 | - | $69.41 M(+2.8%) |
| Mar 2020 | - | $67.51 M(-14.1%) |
| Dec 2019 | $295.04 M(+26.1%) | $78.57 M(+30.3%) |
| Sept 2019 | - | $60.28 M(-19.5%) |
| June 2019 | - | $74.85 M(-8.0%) |
| Mar 2019 | - | $81.34 M(+18.6%) |
| Dec 2018 | $233.90 M(+6.0%) | $68.59 M(+27.0%) |
| Sept 2018 | - | $53.99 M(+6.1%) |
| June 2018 | - | $50.90 M(-15.8%) |
| Mar 2018 | - | $60.42 M(-14.4%) |
| Dec 2017 | $220.74 M(+28.2%) | $70.61 M(+44.6%) |
| Sept 2017 | - | $48.84 M(-1.4%) |
| June 2017 | - | $49.55 M(-4.2%) |
| Mar 2017 | - | $51.74 M(+7.7%) |
| Dec 2016 | $172.16 M(+77.6%) | $48.05 M(+0.7%) |
| Sept 2016 | - | $47.73 M(+10.8%) |
| June 2016 | - | $43.07 M(+29.3%) |
| Mar 2016 | - | $33.31 M(+7.3%) |
| Dec 2015 | $96.92 M(+30.0%) | $31.06 M(+38.1%) |
| Sept 2015 | - | $22.49 M(-2.3%) |
| June 2015 | - | $23.01 M(+13.0%) |
| Mar 2015 | - | $20.36 M(+4.4%) |
| Dec 2014 | $74.56 M(+36.9%) | $19.50 M(+2.9%) |
| Sept 2014 | - | $18.95 M(+0.9%) |
| June 2014 | - | $18.79 M(+8.5%) |
| Mar 2014 | - | $17.32 M(+25.2%) |
| Dec 2013 | $54.46 M(+128.5%) | $13.83 M(+9.2%) |
| Sept 2013 | - | $12.66 M(-16.7%) |
| June 2013 | - | $15.21 M(+19.3%) |
| Mar 2013 | - | $12.75 M(+47.8%) |
| Dec 2012 | $23.83 M(+103.5%) | $8.63 M(+42.5%) |
| Sept 2012 | - | $6.05 M(+38.2%) |
| June 2012 | - | $4.38 M(-8.2%) |
| Mar 2012 | - | $4.77 M(+15.8%) |
| Dec 2011 | $11.71 M(+4.2%) | $4.12 M(+0.7%) |
| Sept 2011 | - | $4.09 M(+128.3%) |
| June 2011 | - | $1.79 M(+4.7%) |
| Mar 2011 | - | $1.71 M(-10.6%) |
| Dec 2010 | $11.23 M(-2.3%) | $1.91 M(-3.7%) |
| Sept 2010 | - | $1.99 M(-53.0%) |
| June 2010 | - | $4.22 M(+35.8%) |
| Mar 2010 | - | $3.11 M(+40.1%) |
| Dec 2009 | $11.50 M(-51.7%) | $2.22 M(-4.6%) |
| Sept 2009 | - | $2.33 M(-41.4%) |
| June 2009 | - | $3.97 M(+33.5%) |
| Mar 2009 | - | $2.98 M(-22.7%) |
| Dec 2008 | $23.81 M(-1.0%) | $3.85 M(-39.3%) |
| Sept 2008 | - | $6.34 M(-0.9%) |
| June 2008 | - | $6.40 M(-11.3%) |
| Mar 2008 | - | $7.22 M(-9.2%) |
| Dec 2007 | $24.05 M(+27.5%) | $7.95 M(+48.4%) |
| Sept 2007 | - | $5.36 M(+15.6%) |
| June 2007 | - | $4.63 M(-24.6%) |
| Mar 2007 | - | $6.15 M(+7.4%) |
| Dec 2006 | $18.86 M | $5.73 M(+45.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2006 | - | $3.95 M(-17.6%) |
| June 2006 | - | $4.79 M(+8.8%) |
| Mar 2006 | - | $4.40 M(+6.8%) |
| Dec 2005 | $13.86 M(-5.8%) | $4.12 M(+29.8%) |
| Sept 2005 | - | $3.17 M(-18.6%) |
| June 2005 | - | $3.90 M(+46.1%) |
| Mar 2005 | - | $2.67 M(-30.1%) |
| Dec 2004 | $14.72 M(+28.4%) | $3.82 M(+11.8%) |
| Sept 2004 | - | $3.42 M(-8.3%) |
| June 2004 | - | $3.73 M(-0.9%) |
| Mar 2004 | - | $3.76 M(+30.7%) |
| Dec 2003 | $11.46 M(+17.9%) | $2.88 M(+14.9%) |
| Sept 2003 | - | $2.50 M(-19.3%) |
| June 2003 | - | $3.10 M(+4.1%) |
| Mar 2003 | - | $2.98 M(+56.6%) |
| Dec 2002 | $9.72 M(-8.2%) | $1.90 M(-28.9%) |
| Sept 2002 | - | $2.68 M(-4.7%) |
| June 2002 | - | $2.81 M(+24.5%) |
| Mar 2002 | - | $2.26 M(-29.1%) |
| Dec 2001 | $10.60 M(+47.6%) | $3.18 M(+13.1%) |
| Sept 2001 | - | $2.81 M(+16.8%) |
| June 2001 | - | $2.41 M(+9.9%) |
| Mar 2001 | - | $2.19 M(-10.3%) |
| Dec 2000 | $7.18 M(+17.6%) | $2.44 M(+46.9%) |
| Sept 2000 | - | $1.66 M(-5.1%) |
| June 2000 | - | $1.75 M(+32.5%) |
| Mar 2000 | - | $1.32 M(-23.5%) |
| Dec 1999 | $6.10 M(+22.0%) | $1.73 M(+15.7%) |
| Sept 1999 | - | $1.49 M(-46.7%) |
| June 1999 | - | $2.80 M(-6.7%) |
| Mar 1999 | - | $3.00 M(-372.7%) |
| Dec 1998 | $5.00 M(-56.1%) | -$1.10 M(-139.3%) |
| Sept 1998 | - | $2.80 M(-12.5%) |
| June 1998 | - | $3.20 M(+10.3%) |
| Mar 1998 | - | $2.90 M(+26.1%) |
| Dec 1997 | $11.40 M(-36.0%) | $2.30 M(-17.9%) |
| Sept 1997 | - | $2.80 M(-9.7%) |
| June 1997 | - | $3.10 M(-3.1%) |
| Mar 1997 | - | $3.20 M(-30.4%) |
| Dec 1996 | $17.80 M(+19.5%) | $4.60 M(0.0%) |
| Sept 1996 | - | $4.60 M(0.0%) |
| June 1996 | - | $4.60 M(+15.0%) |
| Mar 1996 | - | $4.00 M(-4.8%) |
| Dec 1995 | $14.90 M(-6.3%) | $4.20 M(+16.7%) |
| Sept 1995 | - | $3.60 M(-2.7%) |
| June 1995 | - | $3.70 M(+12.1%) |
| Mar 1995 | - | $3.30 M(-21.4%) |
| Dec 1994 | $15.90 M(-15.0%) | $4.20 M(+13.5%) |
| Sept 1994 | - | $3.70 M(-15.9%) |
| June 1994 | - | $4.40 M(+15.8%) |
| Mar 1994 | - | $3.80 M(-26.9%) |
| Dec 1993 | $18.70 M(+88.9%) | $5.20 M(+15.6%) |
| Sept 1993 | - | $4.50 M(-6.3%) |
| June 1993 | - | $4.80 M(+45.5%) |
| Mar 1993 | - | $3.30 M(+22.2%) |
| Dec 1992 | $9.90 M(+73.7%) | $2.70 M(+22.7%) |
| Sept 1992 | - | $2.20 M(-15.4%) |
| June 1992 | - | $2.60 M(+13.0%) |
| Mar 1992 | - | $2.30 M(+64.3%) |
| Dec 1991 | $5.70 M(-3.4%) | $1.40 M(0.0%) |
| Sept 1991 | - | $1.40 M(-12.5%) |
| June 1991 | - | $1.60 M(+14.3%) |
| Mar 1991 | - | $1.40 M(-6.7%) |
| Dec 1990 | $5.90 M(-20.3%) | $1.50 M(0.0%) |
| Sept 1990 | - | $1.50 M(-6.3%) |
| June 1990 | - | $1.60 M(+23.1%) |
| Mar 1990 | - | $1.30 M(-18.8%) |
| Dec 1989 | $7.40 M(-5.1%) | $1.60 M(+6.7%) |
| Sept 1989 | - | $1.50 M(-34.8%) |
| June 1989 | - | $2.30 M |
| Dec 1988 | $7.80 M(+44.4%) | - |
| Dec 1987 | $5.40 M | - |
FAQ
- What is Heron Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Heron Therapeutics?
- What is Heron Therapeutics annual operating expenses year-on-year change?
- What is Heron Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Heron Therapeutics?
- What is Heron Therapeutics quarterly operating expenses year-on-year change?
What is Heron Therapeutics annual total operating expenses?
The current annual operating expenses of HRTX is $172.55 M
What is the all time high annual operating expenses for Heron Therapeutics?
Heron Therapeutics all-time high annual total operating expenses is $295.04 M
What is Heron Therapeutics annual operating expenses year-on-year change?
Over the past year, HRTX annual total operating expenses has changed by -$54.90 M (-24.14%)
What is Heron Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of HRTX is $27.81 M
What is the all time high quarterly operating expenses for Heron Therapeutics?
Heron Therapeutics all-time high quarterly total operating expenses is $81.34 M
What is Heron Therapeutics quarterly operating expenses year-on-year change?
Over the past year, HRTX quarterly total operating expenses has changed by -$10.35 M (-27.11%)